Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03084835 · ClinicalTrials.gov registry record · NA
Low Dose Computed Tomography for Lung Cancer Screening
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03084835: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03084835 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03084835, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that links LDCT-eligible smokers with an evidence-based intervention comprised of a web-based program and integrated text messaging. The goal is to provide actionable findings about how to most effectively and cost efficiently promote abstinence in LDCT clinics.
Primary Outcome
biochemically confirmed 12 month smoking abstinence of WEB+TXT;
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL WEB+TXT
- BEHAVIORAL WEB+TXT+TTS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-08-14 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
Why NCT03084835 stopped before completion
NCT03084835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT03084835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03084835 about?
NCT03084835 is a clinical study titled "Low Dose Computed Tomography for Lung Cancer Screening". This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that links LDCT-eligible smokers with an evidence-based intervention comprised of a web-based program and integrated text messaging. The goal is to provide actionable findings about how to most effectively and cost...
What is the current status of trial NCT03084835?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2017-08-14. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT03084835?
The interventions under investigation include: Usual Care (BEHAVIORAL), WEB+TXT (BEHAVIORAL), WEB+TXT+TTS (BEHAVIORAL).
Who is sponsoring clinical trial NCT03084835?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03084835's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI